GSDMD and inflammatory bowel disease: NSA, as a GSDMD‐targeted inhibitor, can inhibit pyroptosis by inhibiting GSDMD, thereby alleviating a variety of inflammatory diseases, such as inflammatory bowel disease,360 acute liver failure,361 and pulmonary fibrosis362 and is expected to alleviate inflammation related to MDs.